Natco Pharma Launches Carboplatin Injection in U.S. to Address Critical Drug Shortage
Natco Pharma launches Carboplatin Injection, a generic Paraplatin®, in the U.S. market to address critical shortages. Market size estimated at USD 27.8 million.
US Market
Latest US Market stock news from NSE and BSE filings, 6 stories so far.
Product Launched
Granules India Secures Sole First-to-File Status for Sodium Oxybate Generic in US
Granules India secures Sole First-to-File ANDA status for Sodium Oxybate ER, the generic equivalent of LUMRYZ, targeting the US narcolepsy treatment market.
Product Launched
Glenmark Pharmaceuticals Launches Lacosamide Injection in USA Targeting $15.2M Market
Glenmark Pharmaceuticals launches Lacosamide Injection USP in the US market, targeting annual sales of $15.2 million. Learn about this strategic portfolio expansion.
New Order
Aurionpro Solutions Bags Largest US Fintech Order Worth USD 33 Million Over Three Years
Aurionpro Solutions secures a ₹316.80 Cr fintech contract from a US digital insurance platform. Learn about the $33M order scope and its impact on revenue growth.
